Stay updated on GT90001+Nivolumab in Metastatic HCC Clinical Trial

Sign up to get notified when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GT90001+Nivolumab in Metastatic HCC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.6.5 to v3.6.6, indicating a minor backend/content-management update. The visible study information and content appear unchanged.
    Difference
    0.1%
    Check dated 2026-08-29T23:55:02.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    The page revision metadata was updated from v3.6.4 to v3.6.5. This reflects a backend/template update for the page and does not affect the displayed study details.
    Difference
    0.1%
    Check dated 2026-08-08T23:33:29.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page’s revision label in the footer has been updated to v3.6.4, signaling a behind-the-scenes release update without changes to the displayed study details.
    Difference
    0.1%
    Check dated 2026-07-25T15:51:57.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3, representing a minor platform update to the page rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-07-04T04:26:55.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Revision tag on the page footer was updated from v3.6.0 to v3.6.2, reflecting a minor site maintenance update. The content and study details shown on the page remain unchanged.
    Difference
    0.1%
    Check dated 2026-06-27T03:07:10.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    The study details page adds new user guidance sections and standardizes the Intervention/Treatment header; it also marks recruitment as no longer recruiting and updates the revision to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T15:37:45.000Z thumbnail image

Stay in the know with updates to GT90001+Nivolumab in Metastatic HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.